|Day Low/High||8.37 / 8.68|
|52 Wk Low/High||3.91 / 19.49|
Here's the kind I like to buy -- and the vetted stocks that you can play on 'good' risk.
As power has changed hands in the White House, we can expect these names -- and themes -- to benefit.
Let's review the charts and indicators.
I fear our legislators see these statistics and misunderstand the plight of the lower to middle class American in this environment.
What's most interesting about this market is how market players continue to hunt for entries despite all the warnings and negativity.
One is Abbott Labs' announcement of a quick and cheap Covid test.
There is plenty of chasing of the strength which is an indication that FOMO is in overdrive again.
A key indicator signals that a period of sideways price action is likely to continue for a bit in the stock of the provider of 5G wireless hardware.
Many of the smaller stocks I favor have not reported earnings yet and I'm cutting them back.
Despite Wednesday's woes with Stockcharts, I found a trade in this 5G play.
Wild speculative trading continues to be the most fascinating aspect of this market.
A positive aspect of this sort of action is that the best trading opportunities tend to stand out more.
I'm doing some dip buying amid weakness in large-cap tech stocks.
The market trend is up and that's all that matters in the short term.
Bears have been confounded by the positive sentiment, but economic realities are not going to suddenly disappear.
Despite the lackluster action there are some pockets of good stock picking again.
Anyone attempting to navigate this market based on macro-economic analysis is going to have a tough time.
There's a lot moving in this market -- It's all about sector rotation and stock-picking.
This is still a stock-pickers market as pessimists and optimists battle it out.
INSG is entitled to 'catch its breath' and trade sideways for a while.
The chances that we are on the verge of the first real bear market in a decade are quite high.
The biggest complaint I hear from traders is that they can't seem to get money to work.
Two trades I'm making (and one on my radar) as a I stay focused on the price action.
Here are my takes on stocks in biotech and other companies I own right now.
Viavi Solutions has the tools to help operators, services, and network-equipment manufacturers measure performance to optimize connectivity and quality.